Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world (it affects 30% of the general adult population). The NAFLD encompasses a histological spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), defined by steatosis, hepatocel...
Main Authors: | Marilena Durazzo, Paola Belci, Alessandro Collo, Enrica Grisoglio, Simona Bo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2012/464706 |
Similar Items
-
OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
by: Elena Paschetta, et al.
Published: (2015-01-01) -
The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies
by: Marica Meroni, et al.
Published: (2019-11-01) -
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
by: Simona Marchisello, et al.
Published: (2019-04-01) -
History of Nonalcoholic Fatty Liver Disease
by: Amedeo Lonardo, et al.
Published: (2020-08-01) -
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
by: Klementina Fon Tacer, et al.
Published: (2011-01-01)